Thomas combines deep scientific expertise with strong business acumen, bringing over 15 years of experience building and leading biotech ventures. He has founded and scaled multiple companies from concept to clinical stage, securing significant funding and partnerships along the way. His venture partner experience and advisory roles across Kohde Pharma, Encelta, and Gordion Bioscience make him a trusted partner for founders tackling complex, science-driven challenges.

Arman is a PharmD investor with an operator’s execution mindset and Venture Partner background. He brings EMA insights, including experience with the orphan drug designation process, to rigorous, risk-aware diligence. Having lived and worked across three continents, he leverages long-standing relationships and disciplined execution to unlock opportunities others cannot access — converting initial skepticism into durable, repeatable access across healthcare and adjacent sectors.

Armin is a Founding Partner at Mehr and a PharmD investor-operator with global perspective and clinical depth. As a former Collaborating Expert in Pharmacovigilance at the European Medicines Agency, he brings unique insight into the post-approval and real-world use of medicines. With a rigorously detail-oriented approach to due diligence and evaluation, Armin backs world-class founders addressing unmet medical needs at the intersection of science, technology, and healthcare innovation.